Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Steering through complexity: management approaches in multiple sclerosis.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
Methods for identifying subject-specific abnormalities in neuroimaging data.
Neuropharmacological Actions of Metformin in Stroke.
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
New EMA Advice for PML Prevention With Fingolimod in MS
Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Benign neuromyelitis optica is rare in Japanese patients.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
[Pay attention to the differences and similarities in the pathogenesis and management of multiple sclerosis and neuromyelitis optica].
Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
Correction: optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
Analysis of the treatment of neuromyelitis optica.
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial.
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Neuromyelitis optica in a Ugandan woman: a case report.
Progressive multifocal leukoencephalopathy in multiple sclerosis.

Pages